Twente, Netherlands

Jan Feijen


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 246(Granted Patents)


Company Filing History:


Years Active: 2000

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jan Feijen: Innovator in Bioprosthetic Devices

Introduction

Jan Feijen is a notable inventor based in Twente, Netherlands. He has made significant contributions to the field of bioprosthetic devices, particularly through his innovative approaches to collagen-based materials. His work has implications for medical implants and devices that enhance patient care.

Latest Patents

Jan Feijen holds a patent for a "Process for making a bioprosthetic device and implants produced therefrom." This patent describes bioprosthetic devices made of collagen-based material that feature collagen amine groups and collagen carboxyl groups. The methods outlined in the patent involve combining an epoxy functionalized crosslinking agent with the collagen-based material in an aqueous medium at an acidic pH. This process allows for the reaction of a portion of the collagen carboxyl groups with the crosslinking agent, resulting in crosslinked collagen-based material that retains residual collagen carboxyl groups.

Career Highlights

Jan Feijen is associated with Medtronic, Inc., a leading company in the medical technology sector. His work at Medtronic has allowed him to focus on developing advanced bioprosthetic solutions that can improve the quality of life for patients requiring implants.

Collaborations

Throughout his career, Jan has collaborated with notable colleagues, including Marc Hendriks and Michel L Verhoeven. These collaborations have contributed to the advancement of research and development in the field of bioprosthetics.

Conclusion

Jan Feijen's innovative work in bioprosthetic devices exemplifies the intersection of technology and healthcare. His contributions continue to influence the development of medical implants that enhance patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…